The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study
- PMID: 25784017
- PMCID: PMC4537686
- DOI: 10.1007/s00467-015-3074-x
The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study
Abstract
Background: The Patient Reported Outcomes Measurement Information System (PROMIS) II is a prospective study that evaluates patient reported outcomes in pediatric chronic diseases as a measure of health-related quality of life (HRQOL). We have evaluated the influence of disease duration on HRQOL and, for the first time, compared the findings of the PROMIS measures to those of the PedsQL™ 4.0 Generic Scales (PedsQL) from the PROMIS II nephrotic syndrome (NS) longitudinal cohort.
Methods: This was a prospective study in which 127 children (age range 8-17 years) with active NS from 14 centers were enrolled. Children with active NS defined as the presence of nephrotic range proteinuria (>2+ urinalysis and edema or urine protein/creatinine ratio >2 g/g) were eligible. Comparisons were made between children with prevalent (N = 67) and incident (N = 60) disease at the study enrollment visit.
Results: The PROMIS scores were worse in prevalent patients in the domains of peer relationship (p = 0.01) and pain interference (p < 0.01). The PedsQL showed worse scores in prevalent patients for social functioning (p < 0.01) and school functioning (p = 0.03). Multivariable analyses showed that prevalent patients had worse scores in PROMIS pain interference (p = 0.02) and PedsQL social functioning (p < 0.01).
Conclusion: The PROMIS measures detected a significant impact of disease duration on HRQOL in children, such that peer relationships were worse and pain interfered with daily life to a greater degree among those with longer disease duration. These findings were in agreement with those for similar domains in the PedsQL legacy instrument.
Conflict of interest statement
References
-
- Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA. Management of childhood onset nephrotic syndrome. Pediatrics. 2009;124:747–757. - PubMed
-
- Ruth EM, Landolt MA, Neuhaus TJ, Kemper MJ. Health-related quality of life and psychosocial adjustment in steroid-sensitive nephrotic syndrome. J Pediatr. 2004;145:778–783. - PubMed
-
- Gipson DS, Selewski DT, Massengill SF, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Plattner BW, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA. Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes. 2013;11:30. - PMC - PubMed
-
- Gipson DS, Trachtman H, Kaskel FJ, Radeva MK, Gassman J, Greene TH, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Middleton JP, Vehaskari VM, Hogan SL, Vento S, Flynn PA, Powell LM, McMahan JL, Siegel N, Friedman AL. Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney Int. 2011;79:678–685. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- 1U01AR057948/AR/NIAMS NIH HHS/United States
- 1U01AR057967/AR/NIAMS NIH HHS/United States
- U01 AR057929/AR/NIAMS NIH HHS/United States
- U01 AR052181/AR/NIAMS NIH HHS/United States
- 1U01AR052171/AR/NIAMS NIH HHS/United States
- U01 AR057954/AR/NIAMS NIH HHS/United States
- 2U01AR052186/AR/NIAMS NIH HHS/United States
- U01 AR057940/AR/NIAMS NIH HHS/United States
- 1U01AR057940/AR/NIAMS NIH HHS/United States
- 2U01AR052181/AR/NIAMS NIH HHS/United States
- U01 AR057948/AR/NIAMS NIH HHS/United States
- 1U01AR057956/AR/NIAMS NIH HHS/United States
- U01 AR057956/AR/NIAMS NIH HHS/United States
- U01 AR052158/AR/NIAMS NIH HHS/United States
- U01 AR057971/AR/NIAMS NIH HHS/United States
- 1U54AR057951/AR/NIAMS NIH HHS/United States
- 1U01AR057954/AR/NIAMS NIH HHS/United States
- U01 AR057967/AR/NIAMS NIH HHS/United States
- U01 AR052155/AR/NIAMS NIH HHS/United States
- 1U54AR057926/AR/NIAMS NIH HHS/United States
- 2U01AR052158/AR/NIAMS NIH HHS/United States
- 1U01AR057929/AR/NIAMS NIH HHS/United States
- U54 AR057943/AR/NIAMS NIH HHS/United States
- UL1 TR000448/TR/NCATS NIH HHS/United States
- 1U01AR057936/AR/NIAMS NIH HHS/United States
- U01 AR052171/AR/NIAMS NIH HHS/United States
- U01 AR057936/AR/NIAMS NIH HHS/United States
- U01 AR052186/AR/NIAMS NIH HHS/United States
- 2U01AR052155/AR/NIAMS NIH HHS/United States
- U54 AR057951/AR/NIAMS NIH HHS/United States
- 1U54AR057943/AR/NIAMS NIH HHS/United States
- U01AR057971/AR/NIAMS NIH HHS/United States
- U54 AR057926/AR/NIAMS NIH HHS/United States
- KL2 TR000450/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous